| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/02/2007 | US20070178540 Goodpasture antigen binding protein |
| 08/02/2007 | US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual |
| 08/02/2007 | US20070178093 Lymphocytes; methods |
| 08/02/2007 | US20070178092 Humanized anti-CD3 specific antibodies |
| 08/02/2007 | US20070178091 Combination Therapy |
| 08/02/2007 | US20070178082 Stabilized single domain antibodies |
| 08/02/2007 | US20070178079 lactic acid bacterial micro-organisms that have been isolated and selected for their probiotic potential and their use for the preparation of petfood compositions; lactobacilli, bifidobacteria or Enterococci |
| 08/02/2007 | US20070178072 Method for inducing differentiation of regulatory t cells usinggip-anchored protein agonist and pharmaceutical composition therefor ( as amended |
| 08/02/2007 | US20070178052 Delivery of opioids through an inhalation route |
| 08/02/2007 | DE102006003854A1 Preparation of regulatory and cytotoxic CD8+ T cells, useful for treatment and prevention of immune reactions and associated disease, by treating naive cells with alpha-melanocyte-stimulating hormone |
| 08/02/2007 | DE10138935B4 Synthetische Verbindungen vom Nicht-Mucintyp oder ihre mit einem Träger konjugierten Verbindungen, unter deren Verwendung hergestellte monoclonale Antikörper, diese umfassende Antitumormittel Immunstimulantien und Mittel gegen das humane Immundefizienzvirus Synthetic compounds from non-mucin or its conjugated with a carrier compounds monoclonal antibody prepared using them, this comprehensive antitumor agents and immunostimulants agents against human immunodeficiency virus |
| 08/02/2007 | CA2637081A1 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppressive and anti -inflammatory agents |
| 08/02/2007 | CA2636867A1 Vaccines and immunotherapeutics using codon optimized il-15 and methods for using the same |
| 08/02/2007 | CA2636854A1 Ligands that bind il-4 and/or il-13 |
| 08/02/2007 | CA2635124A1 Novel pyridine derivatives |
| 08/01/2007 | EP1813671A1 Soluble protein and utilization of the same |
| 08/01/2007 | EP1813626A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof, antigens recognized thereby and cells obtained thereby |
| 08/01/2007 | EP1813616A2 Pyrazoloquinolines with immunomodulating activity |
| 08/01/2007 | EP1813278A1 Nucleoside analogs with carboxamidine modified monocyclic base |
| 08/01/2007 | EP1812442A2 Imidazo[1,2-a]pyrazin-8-ylamines useful as modulators of kinase activity |
| 08/01/2007 | EP1812408A2 Pyridazine compounds, compositions and methods |
| 08/01/2007 | EP1812055A1 Chlamydia antigens and uses thereof |
| 08/01/2007 | EP1812048A1 Gh secretagogues and uses thereof |
| 08/01/2007 | EP1811998A1 Triazoles useful as inhibitors of protein kinases |
| 08/01/2007 | EP1811997A2 Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors |
| 08/01/2007 | EP1601355B1 Diagnostic method for prevision of kidney transplantation rejection |
| 08/01/2007 | EP1581505B1 Pyridazinone derivatives as gsk-3beta inhibitors |
| 08/01/2007 | EP1572071A4 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/01/2007 | EP1560811B1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 08/01/2007 | EP1546130B1 Piperidine derivatives for use in the treatment of chemokine mediated disease states |
| 08/01/2007 | EP1461326B1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors |
| 08/01/2007 | EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 08/01/2007 | EP1419158B1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 08/01/2007 | EP1332158B1 Peptides, the production and use thereof for binding immunoglobulins |
| 08/01/2007 | EP1330468B1 Sulphur analogues of 21-hydroxy-6,19-oxidoprogesterone (21oh-6op) for treating excess of glucocorticoids |
| 08/01/2007 | EP0986399B1 Chelating immunostimulating complexes |
| 08/01/2007 | EP0884947B1 Dna vaccination for induction of suppressive t cell response |
| 08/01/2007 | CN1329409C Modulation of the expression of genes dependent on STAT-1 |
| 08/01/2007 | CN1329392C Substituted pyrazoles |
| 08/01/2007 | CN1329388C 1,3,5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 08/01/2007 | CN1329374C Compound as CCR5 agonist |
| 08/01/2007 | CN1329372C Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
| 08/01/2007 | CN1329082C Polymer conjugates of interferon beta-1a and their uses |
| 08/01/2007 | CN101010076A Immune function-improving agent |
| 08/01/2007 | CN101010070A Pharmaceutical composition |
| 08/01/2007 | CN101007846A T8 synthetic product and application thereof |
| 08/01/2007 | CN101007803A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/01/2007 | CN101007082A A health mongolian veterinary drug |
| 08/01/2007 | CN101007049A Application of nitric oxide donor and Chinese herbal preparation on nonspecific immune function of prawns |
| 08/01/2007 | CN101007026A An anticancer medicinal composition, preparing method and use thereof |
| 08/01/2007 | CN101006986A Medicinal composition containing mycophonolate mofetil and its preparation method |
| 08/01/2007 | CN101006846A Anti-stress nutrition additives for poultry and its preparation method |
| 08/01/2007 | CN101006807A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 08/01/2007 | CN101006806A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 08/01/2007 | CN101006805A Mix oil containing linoleic acid and linolenic acid in the ratio of 4 to 1 |
| 07/31/2007 | US7250531 Process for the synthesis and crystalline form of agomelatine |
| 07/31/2007 | US7250516 Phenylalanine derivatives |
| 07/31/2007 | US7250420 Using a pyrrolo(2,3-d)pyrimidine compound |
| 07/31/2007 | US7250403 Administration of immunomodulatory polynucleotide microcarrier complexes featuring a polynucleotide comprising at least one immunostimulatory sequence bound to a biodegradable microcarrier or noncarrier |
| 07/31/2007 | US7250173 helminths obtained from preparatory animals raised in a specific human pathogen-free environment used to treat an excessive immune response including an aberrant/enhanced Th1 response, e.g., Crohn's disease and ulcerative colitis |
| 07/31/2007 | US7250168 Oxidative damage and protease activity resistance; catalytic efficiency; deep vein thrombosis, disseminated intravascular coagulation, acute coronary syndrome |
| 07/31/2007 | US7250165 Anti-TNF antibodies, compositions, methods and uses |
| 07/31/2007 | US7250161 Equine GM-CSF |
| 07/31/2007 | CA2412596C Cyclic gmp-specific phosphodiesterase inhibitors |
| 07/31/2007 | CA2240705C Cyclosporin-containing soft capsule preparations |
| 07/26/2007 | WO2007084672A2 Monoclonal antibodies against cd30 lacking in fucosyl and xylosyl residues |
| 07/26/2007 | WO2007084557A2 Azaindoles useful as inhibitors of janus kinases |
| 07/26/2007 | WO2007083759A1 Bone destruction inhibitor comprising anti-ccl20 antibody |
| 07/26/2007 | WO2007083098A1 Cannabinoid-containing plant extracts as neuroprotective agents |
| 07/26/2007 | WO2007082956A1 Thiazole derivatives and use thereof |
| 07/26/2007 | WO2007082475A1 Novel ent-kaurene diterpene compound and its derivatives, their preparation and their use |
| 07/26/2007 | WO2007082470A1 Pyrrolo-pyridazine derivatives,their preparation methods and uses |
| 07/26/2007 | WO2007062175A3 Spiro-substituted tricyclic heterocycles cxcr3 antagonists |
| 07/26/2007 | WO2007047492A3 Increasing thymic output in hiv-negative patients with antiretrovirals |
| 07/26/2007 | WO2007046113A3 Novel pharmaceutical composition comprising alkaloid and process thereof |
| 07/26/2007 | WO2007042573A3 Compositions and methods for treating proliferative disorders |
| 07/26/2007 | WO2007003948A3 Core 2 glcnac-t inhibitors |
| 07/26/2007 | WO2006084264A3 Cd20 antibody variants and uses thereof |
| 07/26/2007 | US20070174922 Nucleic acid encoding novel type-1 cytokine receptor glm-r |
| 07/26/2007 | US20070173525 Receptor or non-receptor types; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, agents; retinal vascularization |
| 07/26/2007 | US20070173502 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 07/26/2007 | US20070173454 Administering an agent that decreases or regulates the blood level, production, function or activity of gonadotropins-leutinizing hormone, follicle stimulating hormone, activin or follistatin; parkinson's disease |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | US20070172927 Immune complexes comprising proteins of human immunodeficiency virus type 2 (HIV-2), antibodies against proteins of HIV-2, methods and kits employing proteins of HIV-2, and immunogenic compositions comprising proteins of HIV-2 |
| 07/26/2007 | US20070172532 Complex Mixtures Exhibiting Selective Inhibition of Cyclooxygenase-2 |
| 07/26/2007 | US20070172516 Increasing of the resorption of substances via skin and mucous membranes |
| 07/26/2007 | US20070172492 Method for fermentation and cultivation, fermented plant extract, fermented plant extract powder, and composition containing the extract of fermented plant |
| 07/26/2007 | US20070172484 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
| 07/26/2007 | US20070172458 IL-6/IL-6R fusion protein |
| 07/26/2007 | US20070172450 Modulation of immune response and methods based thereon |
| 07/26/2007 | DE102006051941A1 Multifunctional active agent mixture, useful as auxiliary material in virus vaccine or vaccine to treat cancer, comprises fraction of specific peptide in polypetide chain and fraction with essential and non-essential amino acids |
| 07/26/2007 | CA2636634A1 Cannabinoid-containing plant extracts as neuroprotective agents |
| 07/26/2007 | CA2636189A1 Azaindoles useful as inhibitors of janus kinases |
| 07/26/2007 | CA2635830A1 Thiazole derivatives and use thereof |
| 07/25/2007 | EP1811033A1 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 07/25/2007 | EP1810979A1 STABILIZED HUMAN IgG4 ANTIBODIES |
| 07/25/2007 | EP1810715A2 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity |
| 07/25/2007 | EP1810691A2 Immunotherapy for reversing immune suppression |
| 07/25/2007 | EP1810683A1 Immunopotentiator and method and apparatus for producing the same |
| 07/25/2007 | EP1809669A2 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |